Concord Biotech LimitedShare price targets & analyst calls
₹1,417.1-30.60 (-2.11%)
As of 4 Sept 2026
Analysts lean BUY·all 1 short-term call is BUY·consensus 1–3M target ₹1,460 (3.0% above CMP)
₹1,460
3.0% above CMP
₹1,460
1 active 1–3M target
1 open
1 BUY · 0 SELL (all horizons)
N/A
4 of 10 closed calls needed
Watch CONCORDBIO for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (5) · loading…
AI1+·1−+6.1% P&L+3.0% upside left
₹1,417.1
CMP
SL
₹1,290
Entry
₹1,335
Target
₹1,460
RVRaja Venkatraman· via LiveMint Buy-or-Sell (topic)5w ago
BUYCONCORDBIOConcord BiotechHorizon: 1–3 Months* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI1+·0−-4.51% realisedNA upside left
SL
₹1,270
Entry
₹1,330
Target
₹1,450
hit 23 Jul 2026, 12:07 pm
ICIDBI Capital· via IDBI Capital Research Calls Telegram7w ago
BUYCONCORDBIOConcord BiotechHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI2+·0−+1.40% realised0.0% upside left
Entry
₹1,356
Target
₹1,375
hit 31 Jul 2026, 9:55 am
AJAnshul Jain, Lakshmishree Investment and Securities· via Business Today5w ago
BUYCONCORDBIOConcord BiotechHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI3+·0−-7.58% realisedNA upside left
₹1,447
At expiry
SL
₹1,437
Entry*
₹1,565.7
Target
₹1,650
expired 31 Aug 2026, 3:30 pm
SBSumeet Bagadia, Choice Broking· via LiveMint Buy-or-Sell (topic)2w ago
BUYCONCORDBIOConcord BiotechHorizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI2+·1−+6.39% realisedNA upside left
₹1,520.1
At expiry
Entry*
₹1,428.8
Target
₹1,550
expired 17 Aug 2026, 3:30 pm
OKOsho Krishan, Angel One· via ET Now4w ago